Filed: 2/14/2024ACC: 0001104659-24-023144
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 39 equity positions with a total reported market value of $177.65M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
39
Positions
$177.65M
Total AUM (reported)
16.33M
Total Shares
Allocation by class
COM$147.23M82.9%
COM NEW$17.28M9.7%
COM SHS$6.35M3.6%
COMMON STOCK$4.27M2.4%
COM PAR $.01$914.2K0.5%
SPONSORED ADR$913.0K0.5%
SPONSORED ADS$681.3K0.4%
Portfolio Concentration
Top 3$46.10M25.9%
4–10$53.79M30.3%
11–25$65.08M36.6%
Rest$12.69M7.1%
Top 3 weight
25.9%
Top 10 weight
56.2%
Voting Authority Distribution
Total shares with voting rights: 16.33M
Sole
Full voting authority
16.33M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole39
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings39
Rows:
RAYZEBIO INC
SOLEShares378.07K
TypeSH
Market value$23.50M
13.23%
Sole
378.07K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares492.15K
TypeSH
Market value$11.62M
6.54%
Sole
492.15K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares366.01K
TypeSH
Market value$10.97M
6.17%
Sole
366.01K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares701.35K
TypeSH
Market value$10.09M
5.68%
Sole
701.35K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares425.13K
TypeSH
Market value$9.82M
5.53%
Sole
425.13K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares117.37K
TypeSH
Market value$7.37M
4.15%
Sole
117.37K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares70.60K
TypeSH
Market value$6.81M
3.83%
Sole
70.60K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares299.64K
TypeSH
Market value$6.68M
3.76%
Sole
299.64K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares115.50K
TypeSH
Market value$6.67M
3.76%
Sole
115.50K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares3.59M
TypeSH
Market value$6.35M
3.58%
Sole
3.59M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares281.50K
TypeSH
Market value$6.13M
3.45%
Sole
281.50K
Shared
0.00
None
0.00
TOURMALINE BIO INC.
SOLEShares231.88K
TypeSH
Market value$6.07M
3.42%
Sole
231.88K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares1.31M
TypeSH
Market value$5.84M
3.29%
Sole
1.31M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares2.37M
TypeSH
Market value$5.49M
3.09%
Sole
2.37M
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares324.60K
TypeSH
Market value$5.21M
2.93%
Sole
324.60K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares119.49K
TypeSH
Market value$5.03M
2.83%
Sole
119.49K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares160K
TypeSH
Market value$4.59M
2.58%
Sole
160K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares76.10K
TypeSH
Market value$4.56M
2.56%
Sole
76.10K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares77K
TypeSH
Market value$4.27M
2.41%
Sole
77K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$3.74M
2.10%
Sole
1.85M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares555.26K
TypeSH
Market value$3.60M
2.03%
Sole
555.26K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares87.50K
TypeSH
Market value$3.11M
1.75%
Sole
87.50K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares69.40K
TypeSH
Market value$2.75M
1.55%
Sole
69.40K
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares132K
TypeSH
Market value$2.70M
1.52%
Sole
132K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares147.84K
TypeSH
Market value$1.97M
1.11%
Sole
147.84K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RAYZEBIO INCSOLE | COM | 378.07K | SH | $23.50M 13.23% | 378.07K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 492.15K | SH | $11.62M 6.54% | 492.15K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 366.01K | SH | $10.97M 6.17% | 366.01K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 701.35K | SH | $10.09M 5.68% | 701.35K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 425.13K | SH | $9.82M 5.53% | 425.13K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 117.37K | SH | $7.37M 4.15% | 117.37K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 70.60K | SH | $6.81M 3.83% | 70.60K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 299.64K | SH | $6.68M 3.76% | 299.64K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 115.50K | SH | $6.67M 3.76% | 115.50K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 3.59M | SH | $6.35M 3.58% | 3.59M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 281.50K | SH | $6.13M 3.45% | 281.50K | 0.00 | 0.00 |
TOURMALINE BIO INC.SOLE | COM | 231.88K | SH | $6.07M 3.42% | 231.88K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 1.31M | SH | $5.84M 3.29% | 1.31M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 2.37M | SH | $5.49M 3.09% | 2.37M | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 324.60K | SH | $5.21M 2.93% | 324.60K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 119.49K | SH | $5.03M 2.83% | 119.49K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 160K | SH | $4.59M 2.58% | 160K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 76.10K | SH | $4.56M 2.56% | 76.10K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 77K | SH | $4.27M 2.41% | 77K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $3.74M 2.10% | 1.85M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 555.26K | SH | $3.60M 2.03% | 555.26K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 87.50K | SH | $3.11M 1.75% | 87.50K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 69.40K | SH | $2.75M 1.55% | 69.40K | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 132K | SH | $2.70M 1.52% | 132K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 147.84K | SH | $1.97M 1.11% | 147.84K | 0.00 | 0.00 |
Page 1 of 2